Kodiak Sciences Inc. has announced promising results from their Phase 1 clinical trial of KSI-301, a novel anti-VEGF compound for the treatment of age-related macular degeneration, retinal vein occlusion, and diabetic macular edema. Currently approved anti-VEGF drugs require several monthly “loading dosages” at the beginning of the treatment regimen. Twelve weeks after a single dose […]
Neovascularization is the term applied to growth of errant blood vessels into the retina. This can occur whenever the retina is compromised by diseases such as age-related macular degeneration, myopic degeneration, or diabetic macular edema. Neovascularization is initially identified during dilated eye examinations, the scheduling of which depends upon the patient’s initiative in acquiring and […]
Prevent Blindness marks January’s National Glaucoma Awareness Month by Offering Information and Resources for Patients and Caregivers Today, nearly three million people ages 40 and older have glaucoma, according to the Prevent Blindness report, “Future of Vision: Forecasting the Prevalence and Costs of Vision Problems.” Those numbers are projected to increase steadily as more baby […]
A well-known standard for publishing for low vision readers has been incorporation of large print, clear fonts, and bold lettering. Now a small study has shown that bold lettering may not be as important as previously thought. A team of researchers reported in December 2018 to the newsfeed of Science Direct that increasing boldness of […]